Study
Molecular and clinical effects of selective TYK2 inhibition with deucravacitinib in psoriasis
| Study ID | Alternative Stable ID | Type |
|---|---|---|
| EGAS00001005875 | Other |
Study Description
Investigate changes in IL-23/Th17- and type I interferon-pathway biomarkers and gene responses, and measures of selectivity for TYK2 over Janus kinases (JAKs) 1–3, in patients with moderate to severe psoriasis receiving deucravacitinib.
Study Datasets 1 dataset.
Click on a Dataset ID in the table below to learn more, and to find out who to contact about access to these data
| Dataset ID | Description | Technology | Samples |
|---|---|---|---|
| EGAD00001008417 |
Transcriptomic profiling of skin biopsies from psoriasis patients following treatment with deucravacitinib
|
120 |
Who archives the data?
